...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Share value

I noticed that on Nov 9, a price of 0.76 US was applied to my Zenith shares. Previously it showed a price of 1.00 with no value attached.

 

TD told me that they had received the price information from an independent source but had no information.

Share
New Message
Please login to post a reply